Supported by an educational grant from Neurocrine Biosciences, Inc.

Homepage

Featured

News
Tardive Dyskinesia Learner Survey
See More
News
Tardive Dyskinesia Learner Survey
News
TD Care Is Evolving: Here’s What That Means for Clinicians
Education
CME: Conference Rewind from Psych Congress Elevate

Faculty

Craig Chepke, MD, DFAPA
Medical Director,
Excel Psychiatric Associates
Rakesh Jain, MD, MPH
Clinical Professor,
Texas Tech - Permian Basin
Desiree Matthews, PMHNP-BC
CEO,
Different MHP, PC
Jonathan Meyer, MD
Voluntary Clinical Professor of Psychiatry,
University of California,
San Diego School of Medicine

Education

View all
CME: Conference Rewind from Psych Congress Elevate
Tardive Dyskinesia (TD) A Quick Guide for Caregivers
CME: Conference Rewind From NP Institute

Videos

View all
Telehealth AIMS Demo
Anticholinergics and VMAT-2 Inhibitors: Different MOAs, Different Results
AIMS Severity Assessment Video Library

Podcasts

View all
TD in Community Psychiatry: A Hidden Epidemic?
Monitoring TD in Long-Term Care or Geriatric Populations
Shared Decision-Making in TD

News

View all
TD Care Is Evolving: Here’s What That Means for Clinicians
Tardive Dyskinesia Learner Survey
Drug-Drug Considerations in TD Treatment

Posters

View all
Patient Perspective on Barriers to Diagnosis and Treatment of Tardive Dyskinesia: Results From a Cross-Sectional Survey
Impact of Tardive Dyskinesia on Clinical Aspects and Quality of Life Based on Individuals’ Underlying Psychiatric Conditions: Interim Analysis of Baseline Data From the IMPACT-TD Registry
Once-Daily Valbenazine for Tardive Dyskinesia or Huntington’s Disease Chorea in Patients with Dysphagia or Swallowing Difficulties